YZR

Co-founders Prof. Dr. Reinhard Meier and Markus Feuerecker lead investment decisions. Meier is a former practicing physician who transitioned into tech investing. Feuerecker is a career healthcare investor with experience across venture, growth, and buyout private equity. The legal or governance documents naming specific committee members are not public.

YZR's sourcing draws on its founders' combined clinical and investment networks across Europe. Meier's medical background provides access to research hospitals and digital health spinouts, while Feuerecker's buyout and growth-stage relationships surface later-stage visibility. The firm also cites its operator experience as a differentiator, claiming that its team of physicians, scientists, and exited founders generates referrals from within the European health-tech ecosystem.

YZR operates as an independent, founder-led venture capital firm, not a family office or corporate venture arm. It raises external capital, though it does not disclose its limited partner base. The firm describes itself as a sector-specialist, independent investment platform dedicated entirely to healthcare innovation.

YZR invests directly in operating companies and leads or co-leads funding rounds. There is no public evidence that the firm makes fund-of-fund commitments or allocates capital to other external VC managers.

YZR focuses on early-stage HealthTech companies, typically entering at pre-Seed, Seed, or Series A, with opportunistic Series B participation. The firm states it is comfortable leading rounds and providing hands-on support from a company's earliest institutional financing.

Advisory board members like Dr. Michael Bitzer, former CEO of Daman Insurance, and Elmar Willebrand, former Group CEO of Asklepios Clinics, are not operating executives of the firm. YZR includes them as strategic advisors whose industry relationships and operational knowledge inform investment decisions and portfolio support, without indicating they serve on the formal investment committee.

There is no disclosed philanthropic vehicle, foundation, or donor-advised fund associated with YZR or its founders. The firm's public materials focus exclusively on its for-profit venture capital activities.